Is interim 18F-fluoride PET/CT a predictor of outcomes after radium-223 therapy?

by Elba Etchebehere, Ana Emília Brito, Kalevi Kairemo, Eric Rohren, John Araujo, Homer Macapinlac

Prostate cancer – Therapy with radium-223

by Ana Emília Brito, Bárbara Juarez Amorim, Milena Martello, Wanderley Marques Bernardo, Elba Etchebehere

SPECT/CT with 99mTc-sestamibi for the evaluation of skeletal muscle perfusion after electrical muscle stimulation in athletes

by Beatriz Birelli, Mauricio Oliveira, Allan de Oliveira Santos, Willians Manso, Andreia Vicente, Elba Etchebehere
Published 2019-02-01

18F-FDG PET/CT performed immediately after percutaneous ablation to evaluate outcomes of the procedure: preliminary results

by Juliana Romanato, Marcos Roberto Menezes, Allan de Oliveira Santos, Regis Otaviano Franca Bezerra, Mariana Cunha Lopes Lima, Elba Etchebehere

Impact of 68GA-PSMA PET / CT on treatment of patients with recurrent / metastatic high risk prostate cancer - a multicenter study

by Aline B. Mattiolli, Allan Santos, Andreia Vicente, Marcelo Queiroz, Diogo Bastos, Daniel Herchenhorn, Miguel Srougi, Fabio A. Peixoto, Lisa Morikawa, João Luiz Fernandes da Silva, Elba Etchebehere